background
hematopoiet
cell
transplant
hct
recipi
frequent
infect
respiratori
virus
rv
upper
respiratori
tract
urt
concord
urt
lower
respiratori
tract
lrt
rv
detect
well
character
method
hematopoiet
cell
transplant
candid
recipi
respiratori
symptom
lrt
urt
rv
test
via
multiplex
pcr
includ
logist
regress
model
use
analyz
risk
factor
lrt
rv
detect
result
twohundr
thirtyf
hct
candid
recipi
urt
lrt
rv
test
within
day
among
subject
posit
rv
discord
sampl
pair
forti
percent
discord
pair
posit
lrt
neg
urt
discord
common
adenoviru
metapneumoviru
rhinoviru
parainfluenza
viru
type
respiratori
syncyti
viru
highli
concord
likelihood
lrt
detect
increas
urt
detect
ood
ratio
confid
interv
ci
cytomegalovirusposit
recipi
ci
conclus
high
rate
discord
observ
certain
rv
bronchoalveolar
lavag
sampl
may
provid
use
diagnost
inform
guid
manag
symptomat
hct
candid
recipi
respiratori
viru
infect
major
caus
mortal
morbid
hematopoiet
cell
transplant
hct
recipi
although
symptomat
patient
frequent
test
virus
upper
respiratori
tract
urt
lower
respiratori
tract
lrt
test
bronchoscopi
andor
bronchoalveolar
lavag
bal
done
less
frequent
often
prompt
clinic
deterior
evalu
find
radiolog
imag
studi
assess
correl
concurr
urt
lrt
test
respiratori
virus
hct
pretranspl
candid
posttranspl
recipi
studi
examin
differ
respiratori
viral
detect
polymeras
chain
reaction
pcr
upper
lower
tract
sampl
immunocompet
children
chronic
respiratori
symptom
pair
nasopharyng
np
aspir
bal
sampl
show
discord
approxim
one
third
patient
posit
np
aspirateneg
bal
discord
common
small
studi
adult
major
hct
recipi
hematolog
malign
match
np
bal
specimen
pcrbase
np
test
respiratori
virus
patient
clinic
evid
lrt
diseas
high
neg
predict
valu
npv
lower
posit
predict
valu
ppv
larger
studi
includ
mostli
immunocompromis
patient
conclud
pathogen
respiratori
viru
bacteri
pathogen
detect
multiplex
pcr
panel
alreadi
identifi
np
sampl
bal
test
unlik
provid
addit
inform
howev
signific
number
subject
pathogen
detect
bal
without
posit
np
sampl
likewis
studi
lung
transplant
recipi
viral
detect
exclus
lrt
report
thu
author
caution
use
urt
sampl
alon
rule
lrt
infect
popul
studi
aim
describ
discord
hct
candid
recipi
character
specif
viral
patient
treatment
risk
factor
associ
lrt
detect
addit
use
quantit
pcr
methodolog
aim
defin
role
viral
load
respiratori
viru
lrt
detect
retrospect
identifi
hct
pretranspl
candid
within
day
hct
posttranspl
recipi
underw
bal
day
np
aspir
test
respiratori
specimen
multiplex
pcr
test
total
exactli
hct
recipi
underw
bal
respiratori
viru
test
studi
period
clinic
indic
bronchoscopi
lrt
symptom
andor
radiograph
abnorm
determin
pulmonologist
bal
gener
perform
either
rulein
respiratori
viral
involv
lrt
andor
rule
altern
caus
lrt
process
bal
collect
per
institut
standard
practic
use
three
aliquot
normal
salin
cohort
identifi
subject
urt
viral
pcr
test
nasal
wash
np
swab
within
day
within
day
bal
first
bal
per
subject
includ
analysi
cycl
threshold
ct
use
proxi
viral
load
compar
upper
lower
respiratori
sampl
pair
posit
viru
given
subject
patient
chart
review
steroid
use
radiolog
result
presenc
copathogen
potenti
altern
diagnos
steroid
dose
defin
highest
dose
steroid
milligramskilogram
per
day
express
equival
dose
prednison
week
preced
bal
comput
tomographi
chest
obtain
within
week
bal
review
chose
categor
imag
result
presenc
versu
absenc
solitari
nodul
patient
solitari
nodul
may
carri
altern
diagnosi
lower
risk
viral
lrt
involv
copathogen
defin
follow
bacteri
colonyform
unit
gramposit
organ
gramneg
organ
bal
viral
respiratori
viru
detect
bal
multiplex
pcr
cytomegaloviru
cmv
shell
vial
posit
fungal
posit
serum
bal
galactomannan
bal
fungal
pcr
posit
bal
fungal
cultur
posit
exclud
candida
speci
altern
diagnos
includ
diffus
alveolar
hemorrhag
base
find
progress
bloodi
fluid
return
bal
discord
defin
either
urt
sampl
posit
respiratori
viru
pair
lrt
sampl
neg
viru
term
positiveneg
pn
urt
sampl
neg
respiratori
viru
pair
lrt
sampl
posit
viru
term
negativeposit
np
posit
concord
defin
urt
lrt
pair
sampl
posit
viru
pp
neg
concord
defin
urt
lrt
pair
sampl
neg
viru
nn
sensit
specif
lrt
detect
ct
valu
urt
plot
gener
receiv
oper
characterist
roc
curv
ct
valu
subject
neg
test
urt
set
upper
limit
assay
detect
allow
inclus
subject
roc
analysi
posit
neg
predict
valu
lrt
infect
plot
function
possibl
ct
valu
cutpoint
logist
regress
model
use
evalu
odd
ratio
associ
candid
risk
factor
viral
lrt
detect
patient
viru
detect
urt
n
exclud
logist
regress
analysi
patient
cohort
lrt
detect
adenoviru
also
adenoviru
test
plasma
pcr
viremia
patient
dissemin
adenoviru
evidenc
posit
plasma
pcr
time
lrt
detect
n
exclud
logist
regress
roc
analysi
variabl
p
univari
analysi
candid
multivari
model
retain
model
remain
signific
modifi
effect
anoth
factor
confound
covari
evalu
candid
risk
factor
inclus
multivari
model
list
tabl
statist
signific
defin
p
sa
version
sa
institut
inc
cari
nc
use
statist
analys
identifi
subject
bal
perform
studi
period
urt
rv
test
within
day
bal
tabl
show
demograph
characterist
cohort
major
patient
year
age
male
major
patient
underw
allogen
transplant
bal
hct
median
number
day
bal
nasal
swab
day
tabl
also
show
demograph
subset
subject
cohort
urt
lrt
test
within
day
subset
larg
repres
whole
cohort
among
sampl
pair
overal
cohort
posit
respiratori
viru
either
urt
lrt
concord
posit
viru
upper
lower
tract
pp
discord
note
sampl
pair
among
discord
pair
posit
urt
neg
lrt
pn
neg
urt
posit
lrt
np
figur
show
distribut
concordancediscord
pair
least
test
posit
individu
virus
patient
underw
bal
within
day
np
aspir
discord
urt
lrt
result
observ
highest
rate
hmpv
posit
pair
np
pn
hrv
posit
pair
np
pn
posit
pair
np
posit
pair
np
pn
figur
pair
posit
adenoviru
result
discord
np
pn
respiratori
syncyti
viru
highest
frequenc
percentag
concord
result
posit
pair
concord
pn
np
pair
similar
pattern
discord
observ
analyz
patient
underw
bal
within
day
np
aspir
figur
analyz
subset
patient
underw
bal
posit
np
aspir
supplement
figur
ct
valu
virus
group
togeth
urt
lrt
concord
pair
significantli
differ
bal
perform
either
day
urtlrt
p
day
urtlrt
p
collect
urt
specimen
distribut
copathogen
altern
diagnos
examin
concord
posit
pair
discord
pair
figur
aspergillu
fumigatu
anoth
respiratori
viru
bacteria
commonli
identifi
copathogen
signific
differ
observ
proport
copathogen
altern
diagnos
subject
discord
test
versu
concord
posit
result
fisher
exact
test
univari
analysi
risk
factor
lrt
detect
detect
viru
urt
confid
interv
ci
recipi
cmv
seroposit
ci
associ
increas
risk
lrt
detect
tabl
note
factor
found
associ
lrt
detect
includ
condit
regimen
transplant
type
allogen
versu
autolog
steroid
use
presenc
solitari
nodul
imag
lymphocyt
neutrophil
monocyt
overal
white
blood
cell
count
multivari
analysi
detect
viru
urt
ci
recipi
cmv
seroposit
ci
remain
strongli
associ
increas
risk
lrt
detect
tabl
analysi
subset
patient
underw
bal
within
day
np
aspir
separ
analysi
subset
hct
recipi
underw
bal
transplant
yield
similar
result
supplementari
tabl
proport
patient
posit
lrt
sampl
similar
patient
urt
test
lrt
test
versu
lrt
test
thirtyday
mortal
patient
posit
respiratori
viral
test
lrt
compar
neg
test
although
differ
statist
signific
p
roc
curv
gener
summar
sensit
specif
vari
ct
cutpoint
urt
presenc
lrt
infect
ct
cut
point
urt
sensit
specif
wherea
cutpoint
sensit
specif
figur
use
ct
cutoff
urt
preval
lrt
infect
cohort
ppv
npv
lrt
infect
figur
higher
ct
valu
urt
ppv
declin
wherea
npv
lrt
infect
increas
comparison
posit
test
urt
ppv
npv
present
studi
character
rate
discord
respiratori
viral
detect
match
urt
lrt
sampl
larg
cohort
hct
candidatesrecipi
underw
bal
suspect
lrti
concomit
urt
test
demonstr
high
discord
rate
hrv
hmpv
adenoviru
urt
lrt
furthermor
identifi
risk
factor
detect
respiratori
virus
lung
hct
candid
recipi
includ
viral
detect
np
recipi
cmv
seroposit
advent
molecular
test
high
rate
discord
observ
rapid
antigen
detect
assay
sensit
urt
specimen
lrt
specimen
immunocompromis
adult
discord
molecular
diagnost
test
urt
lrt
specimen
also
report
studi
particularli
immunocompromis
popul
patient
posit
lrt
specimen
concord
urt
specimen
posit
npv
urt
test
respect
differ
studi
hct
recipi
hmpv
rsv
detect
lrt
discord
neg
test
hmpv
wherea
patient
discord
neg
test
rsv
present
studi
found
high
level
discord
sampl
pair
among
subject
posit
test
show
discord
urt
lrt
test
viru
although
sampl
size
small
viru
perform
statist
test
discord
rate
highest
hmpv
hrv
adenoviru
note
discrep
present
also
among
patient
urt
specimen
obtain
within
day
bal
human
metapneumoviru
lrt
diseas
associ
high
mortal
hct
recipi
result
suggest
neg
urt
specimen
may
suffici
rule
lrt
infect
note
adenoviru
test
show
discord
everi
subject
viru
reactiv
tissu
follow
viremia
dissemin
lung
may
contribut
find
contrast
rsv
test
show
approxim
concord
suggest
patient
rsv
detect
urt
clinicalradiograph
evid
lrt
involv
may
presum
rsv
lrt
patient
could
treat
accordingli
rsv
pneumonia
also
enrol
clinic
trial
previous
categor
lrt
infect
respiratori
virus
group
depend
viral
detect
lrt
proven
lrti
defin
posit
lrt
sampl
bal
lung
biopsi
autopsi
specimen
radiograph
abnorm
probabl
lrti
defin
posit
lrt
sampl
without
radiograph
abnorm
possibl
lrti
defin
posit
urt
sampl
radiograph
abnorm
lrt
sampl
shown
subject
possibl
lrti
outcom
similar
urt
infect
piv
rsv
subject
provenprob
lrti
wors
outcom
includ
need
oxygen
oxygenfre
day
mortal
result
suggest
lrt
test
stratifi
patient
possibl
versu
provenprob
lrti
provid
use
prognost
inform
hct
recipi
may
becom
increasingli
import
new
antivir
develop
mani
evalu
depend
site
infect
upper
versu
lower
tract
studi
includ
patient
posit
respiratori
viru
lrt
neg
urt
five
virus
name
adenoviru
influenza
hmpv
hrv
np
discord
thu
proxim
urt
test
identifi
lrt
pathogen
case
includ
virus
may
warrant
treatment
current
antivir
influenza
adenoviru
well
virus
specif
antivir
therapi
develop
piv
hmpv
probabl
detect
viru
lrt
increas
patient
viru
detect
urt
studi
found
associ
higher
respiratori
viral
load
sever
diseas
manifest
found
lower
ct
valu
urt
associ
higher
ppv
lrt
infect
howev
npv
appear
plateau
npv
ct
valu
similar
npv
neg
test
urt
vs
respect
import
note
even
neg
pcr
urt
fulli
predict
ct
valu
virus
detect
urt
use
rule
lrt
involv
also
found
cmvseroposit
hct
recipi
increas
risk
lrt
respiratori
viru
detect
previous
report
recipi
cmv
seroposit
risk
factor
respiratori
viru
acquisit
progress
lrt
infect
hct
anoth
studi
report
associ
cmv
reactiv
rsv
infect
hct
develop
sever
pneumonia
cytomegaloviru
seroposit
reactiv
associ
increas
morbid
mortal
graftversushost
diseas
hct
pathogenesi
cmv
infect
diseas
complex
sever
immunomodul
interact
cmv
immun
system
includ
effect
human
leukocyt
antigen
express
cytokin
product
review
refer
find
suggest
increas
risk
lrt
infect
may
anoth
indirect
effect
cmv
furthermor
observ
trend
toward
decreas
risk
detect
viru
lrt
patient
transplant
trend
toward
decreas
risk
patient
transplant
compar
possibl
could
secondari
decreas
viru
detect
urt
later
year
neg
result
urt
strongli
associ
lower
risk
lrt
detect
reduct
urt
respiratori
viral
detect
may
also
secondari
improv
infect
control
practic
altern
trend
toward
reduc
risk
lrt
detect
later
year
may
reflect
practic
chang
either
delay
transplant
patient
posit
test
respiratori
virus
urt
fewer
bronchoscopi
perform
compar
past
could
led
sampl
bia
recent
year
bronchoscopi
often
perform
lung
diseas
due
altern
nonrespiratori
viral
process
suspect
also
sought
understand
differ
viral
load
observ
concord
upper
lower
sampl
signific
differ
viral
load
upper
versu
lower
tract
analyz
virus
togeth
patient
bal
within
day
day
urt
test
one
argument
earli
bronchoscopi
test
viral
lrt
involv
includ
notion
virus
urt
may
push
lrt
procedur
lower
respiratori
tract
posit
could
also
simpli
reflect
upper
tract
secret
aspir
procedur
similar
find
oral
flora
bacteri
cultur
bal
find
sever
case
posit
test
nose
yet
neg
test
lung
argu
push
virus
urt
lrt
bronchoscopi
detect
virus
lrt
artifact
contamin
urt
bronchoscopi
sampl
size
small
support
analysi
ct
valu
individu
virus
studi
sever
limit
first
even
though
sampl
size
rel
larger
studi
immunocompromis
patient
pair
urt
lrt
sampl
could
evalu
risk
factor
discord
individu
virus
second
data
collect
retrospect
therefor
need
sampl
urt
lrt
determin
clinician
patient
popul
limit
underw
bal
within
day
np
aspir
viral
detect
lrt
outcom
measur
therefor
risk
factor
may
differ
patient
undergo
urt
test
third
primari
analysi
focus
hct
recipi
undergon
bal
within
day
np
aspir
could
consid
long
time
period
import
howev
result
analysi
similar
patient
undergon
bal
within
day
np
aspir
fourth
differ
sampl
lrt
bal
urt
swab
may
contribut
differ
ct
valu
higher
collect
volum
bal
compar
np
aspir
approxim
vs
ml
would
gener
lead
higher
ct
valu
lrt
specimen
due
greater
dilut
fifth
antivir
therapi
patient
influenza
rsv
detect
np
aspir
may
affect
detect
virus
bal
howev
found
almost
everi
case
rsv
infect
concord
case
influenza
discord
pn
sixth
copathogen
altern
diagnos
identifi
mani
patient
definit
conclud
whether
lrt
symptom
sign
radiograph
abnorm
caus
specif
respiratori
viru
copathogen
andor
concomit
noninfecti
process
final
ct
valu
may
generaliz
differ
assay
compar
true
viral
load
measur
copiesmillilit
even
though
current
avail
commerci
pcr
assay
includ
ct
valu
studi
show
predict
valu
result
lrt
infect
summari
data
demonstr
discord
urt
lrt
respiratori
viru
detect
sever
common
respiratori
virus
suggest
earli
lrt
viral
test
could
provid
use
diagnost
inform
may
affect
manag
respiratori
viral
infect
certain
hct
candid
recipi
